Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2006-11-14
pubmed:abstractText
Interferon inhibitory activity (IIA) is a logical candidate for explaining neutralizing antibody-negative partial responsiveness to interferon beta in multiple sclerosis (MS), but its role has not been evaluated.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0003-9942
pubmed:author
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1579-84
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Interferon inhibitory activity in patients with multiple sclerosis.
pubmed:affiliation
Department of Cell and Molecular Biology, Roswell Park Cancer Institute, Jacobs Neurological Institute, , Buffalo, New York 14263, USA. Kailash.Chadha@RoswellPark.org
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Evaluation Studies